Skip to content
Axcess News – Lifestyle
Author:
Hyperscale Data Inc.
Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 “Lithium in Brain” Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions
March 26, 2026
←
Previous Page
1
2
3